Third Harmonic Bio Dividends and Buybacks

Dividend criteria checks 0/6

Third Harmonic Bio does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-9.2%

Buyback Yield

Total Shareholder Yield	-9.2%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

Third Harmonic Bio (NASDAQ:THRD) Is In A Good Position To Deliver On Growth Plans

Nov 16

Companies Like Third Harmonic Bio (NASDAQ:THRD) Can Afford To Invest In Growth

Aug 03

Here's Why We're Not At All Concerned With Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation

Apr 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if THRD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if THRD's dividend payments have been increasing.

Dividend Yield vs Market

Third Harmonic Bio Dividend Yield vs Market

How does THRD dividend yield compare to the market?
Segment	Dividend Yield
Company (THRD)	n/a
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.2%
Industry Average (Pharmaceuticals)	2.4%
Analyst forecast (THRD) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate THRD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate THRD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate THRD's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as THRD has not reported any payouts.

Third Harmonic Bio Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

Third Harmonic Bio (NASDAQ:THRD) Is In A Good Position To Deliver On Growth Plans

Companies Like Third Harmonic Bio (NASDAQ:THRD) Can Afford To Invest In Growth

Third Harmonic Bio, Inc. Announce Resignation of Rob Perez as a Class I Director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and A Member of the Audit Committee of the Board

Chief Development Operations Officer notifies of intention to sell stock

Third Harmonic Bio, Inc. Announces the Appointment and Promotion of Key Executive Leaders to the Organization

Third Harmonic Bio, Inc., Annual General Meeting, Jun 06, 2024

CEO & Director notifies of intention to sell stock

Here's Why We're Not At All Concerned With Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation

High number of new directors

Third Harmonic Bio, Inc. Appoints Geoff Mcdonough to Its Board of Directors

Chief Administrative Officer notifies of intention to sell stock

Third Harmonic Bio, Inc. Announces Resignation of Robert Ho as Chief Financial Officer, Effective November 10, 2023

We're Hopeful That Third Harmonic Bio (NASDAQ:THRD) Will Use Its Cash Wisely

Third Harmonic Bio, Inc Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

We're Hopeful That Third Harmonic Bio (NASDAQ:THRD) Will Use Its Cash Wisely

Third Harmonic Bio, Inc. Announces Resignation of Shao-Lee Lin as Class II Director and Chairperson of the Nominating and Governance Committee of the Board

High number of new directors

Third Harmonic Bio Announces Discontinuation of Phase 1B Study of Thb001 in Chronic Inducible Urticaria

We're Not Very Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Rate

Third Harmonic Bio, Inc. has completed an IPO in the amount of $185.3 million.

Third Harmonic Bio, Inc. has completed an IPO in the amount of $185.3 million.

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies